chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a consumer concerning her current 6 year old daughter who at the age of 2 years (approximately in 2006) was vaccinated with a dose of MUMPSVAX II (Lot# not reported). The patient's mother stated that, six hours after the child had received the vaccine she began to had focal seizures affecting her right side. The child was taken to the Emergency Room at the hospital where she was evaluated and continued to have several additional seizures. Her physician had recommended seizure medication for the child, but the parents decided not to have her on it. The mother's patient also stated that her daughter did not have any residual effects from the incident. Upon internal review seizures were determined to be an other important medical event. Additional information has been requested.
This spontaneous report as received from a healthcare professional refers to an unspecified number of patients of an unknown age and gender. Medical history and concurrent conditions were not reported. In approximately 2015 (reported as since 13-MAR-2015), the patients were vaccinated with doses of oral, ROTATEQ lot # K015816 (expiration dates, dose, route and site of administrations were reported) that were exposed tot temperatures outside of the recommended range. No adverse effects had been observed or reported. This is one of several reports from the same reporter. Additional information has been requested.
3 days post injection patient developed increasing dizziness, light headedness, headache, nausea, achey muscles, decreased appetite, shortness of breath with exercise (new complaint), slight cough symptoms persist still 11 days after injection
Patient calls Urgent Care regarding possible adverse reaction to COVID-19  vaccination. States he did ok during the 15 minute wait period after the  injection. Then awhile later he became confused, became dizzy, feeling weird  overall, and has slurred speech (which nurse noticed while talking to the  patient).  Instructed patient to go straight to the Urgent Care immediately.  Patients states family will take him.  Unknown if patient actually went, could not reach patient via phone for follow up.
stomatitis, swelling of arm  Narrative: Employee reported reaction of swelling arm and stomatitis from a covid vaccine employee got from outside source. No record of any covid vaccine administration from facility.
Systemic: Seizure-Medium, Systemic: Shakiness-Medium, Additional Details: PATIENT WAS PANICKING BEFORE GETTING THE SHOT. AFTER RECEIVING THE VACCINE SHE STARTED HAVING A PANIC ATTACK. AFTER ABOUT 10 MINUTES OF THE ATTACK SHE FELT A LITTLE BETTER.  A FEW MINUTES AFTER SHE STARTED HAVING A SEIZURE. THE EMERGENCY ARRIVED RIGHT BEFORE SHE HAD THE SEIZURE.
5DEC94 8PM noted swelling rt deltoid; 11PM c/o pain @ inj site; 6DEC94 area about 50mm over rt deltoid edematous & painful to touch; 7DEC94 phoned pt states is now having shooting pain in arms; urged to see MD;
Severe dizziness & nausea. Needed help standing & walking. B/P normal for her.  Went to bed & slept for about 4 hrs. Just mild dizziness on waking. That resolved in a few hrs. No symptoms since then.
I woke up with severe sinus pressure and I ended up having fever, nausea, vomiting, diarrhea, loss of taste and smell. I tested positive for COVID-19 on Tuesday 08/03/2021. On Friday I had the antibody infusion and on Saturday I felt better. They recommended that we take vitamin C, zinc, vitamin D3, Quercetin, Melatonin, Aspirin, and we had 2 prescriptions, a z-pack, and another prescription. I went back to the doctor's office, and they did an EKG, and it came back normal. My taste and smell are not back completely.
This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 73-year-old female patient who received SHINGRIX (batch number 32GR4, expiry date unknown) for prophylaxis. On 1st June 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional information was received as follows: The healthcare professional reported that the patient developed shingles after receiving the dose of the SHINGRIX series. The healthcare professional did not have correct expiration date of the vaccine.
Day after vaccine 2: Sore throat strep like symptoms and throat ulcer (size: tip of a pencil eraser), sought treatment at urgent care Clinic, strep test negative, negative for covid, negative for walking pneumonia, negative for mono, got antibiotic Rx. Began to feel better with antibiotics within a day, fully resolved within 4-5 days.  After vaccine 3: Nurse at the Pharmacy injected my 3rd dose directly into my right shoulder joint. I could not use my arm for 3 days due to joint pain, couldn't sleep, gradually got range of motion back starting on day 4 but still in pain for about 1 week as a result of poorly placed injection.
Information has been received from a consumer concerning her daughter who on a date not reported was vaccinated with GARDASIL.  Subsequently the patient was temporarily paralyzed.  Upon internal review paralysis was consider to be an other important medical event.  It was unknown if the patient sought medical attention.  No further information is available.
This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced adverse events nos (not specified). The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of adverse events nos (not specified) was not reported. This report was non-serious.
Participant advised nurse of dull pain at injection site, following numbness in fingers and hand and also swelling of hand. approx 1hr 20 min later reporting inability to lift arm.
Patient inadvertently received vaccine after published expiration date. Moderna Company analyzed lot 007B21A and advised vaccine maintained activity needed to protect against covid 19  date vaccine administered. Patient also did not call in with complaint of adverse event.  This is administrative error without adverse event.
Following the 2nd dose of GARDASIL patient had what seemed to be a fainting episode followed by shaking of body, rolling up the eyes but no sphincter relaxation.  The episode lasted a few seconds, patient recovered and had no recollection of the event.  Vitals were normal.
6x8cm area of swelling, redness & heat to lt deltoid where DTP was adm yesterday; c/o hurting all noc;
rash; itching; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash) and PRURITUS (itching) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No medical history was provided by reporter.     On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (rash) and PRURITUS (itching). At the time of the report, RASH (rash) and PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported  No treatment information was provided.
Rt eye watery 1 day after vaccination til present. Cannot fully close Rt eye. Left lip (upper) droop possible Bells Palsy.
Numbness in my coccyx and sort of up into my nose; Feeling weak in my legs like there is weakness in my legs; Tingling in my lips; Allergic reaction; This is a spontaneous report from a contactable consumer (patient). A 58-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number and Expiry date was unknown), via intramuscular, administered in Arm Left on 24Mar2021 (at the age of 58-years-old) as dose 1, single for covid-19 immunization (got it at a school). Medical history included allergies from an unknown date and unknown if ongoing. Patient concomitant medications were not reported. The patient stated she got the Pfizer vaccine (Covid Vaccine) today and she was experiencing numbness in her coccyx and sort of up into her nose. She was like feeling weak in her legs like there was weakness in her legs. Also, she was feeling like a tingling in her lips. Was that like, would you say, that it was allergic reaction to the vaccine itself. She did take allergy and sinus medicine (treatment) because she do have allergies (history) but she just took one just in case to try and stop whatever was happening. Consumer further stated, do you think she should be worried about this reaction she was having with her lips. She also want to know if should get the second dose. Due Date for Second Shot was 14Apr2021. Consumer stated, it was just persisting. Consumer stated she did take Ibuprofen, it was just one Advil and then the Tylenol, 325mg Acetaminophen and when she had the symptoms of the numbness, she took an allergy sinus pill because it had the Benadryl in it, trying to stop any reaction she would have, hoping to. She just took one allergy and sinus pill (took Phenylephrine and Chlorpheniramine). Outcome of all events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
SHIVERING; NAUSEATED DRIVING BACK HOME; FEVER; BODY ACHES; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 28-MAR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On 28-MAR-2021, the subject experienced body aches. On 28-MAR-2021, the subject experienced nauseated driving back home. On 28-MAR-2021, the subject experienced fever. On 29-MAR-2021 04:00, the subject experienced shivering. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, and body aches, and the outcome of nauseated driving back home and shivering was not reported. This report was non-serious.
Developed low grade fever a couple of hours after vaccines. Refusal to eat and vomiting. Hospitalized, IV fluids and ton monitoring. Hospitalized until eating again and vomiting resolved.
24 hrs p/vax cried w/unusual high pitched cry for 1/2 hrs, then seemed nl;
Mom says she was breathing shallow, was cold to touch, pale and just seemed to be like a zombie for a week. No rash.
C/O severe itching left plam and mod. itching bottom of left foot. He scratched his palm so much that it was raw. Resolved in 2 days.
I received cough; headache and fatigue about 7 days, but, cough is still there. My doctor prescribed PAXLOVID.
No fevers. Received Vaccine on 22 Jun 10. Same day, onset local tenderness, swelling followed by joint pains and worsening of chronic headaches. Feeling much better 24 Jun 10.
I had a sore throat, nasal congestion, and cough. I tested positive for COVID-19. I spoke to my doctor, and they prescribed me Paxlovid. I stop taking Paxlovid after two days because it gave me diarrhea and a horrible taste in my mouth.
On the night of  February 25 (day 6/7) I woke up in the middle of the night with my hands itching and right butt cheek.  In the morning, there were a couple  small hives between my fingers on left hand and a larger one on right butt cheek.  I was able to go about my day, periodically itching.  That night, I woke up more frequently in the night with both hands itching.  Primarily in between my fingers and a few small hives on both ankles.  At 11 AM, I noticed a lesion on my tongue.  By Friday night I had several more spots and the itching continued to become more bothersome.  I took benadryl before bed.  I woke up Saturday morning at 1 AM with my tongue swollen and  lower right lip swollen as well.  These did not itch nor hurt.  My hands itched and burned very intensely, I put ice on them for some relief.  There were more hives on my hands, ankles,  left shin and left knee and right elbow.  I went into urgent care at 9 am.  Dr prescribed Prednisone and benadryl.  Dr. only looked at my hands and mouth.  When I got home I noticed I had a large hive bout 2" by 4"above the injection site on my right arm.  This did itch, however was not a major concern because my hands hurt quite severely.  I took benedryl at noon on Saturday and that did bring the swelling of my lips and tongue down.  I could not sleep at all on Saturday night due to the pain and itching.  Once the prednisone took effect, I finally got some relief.  Monday I went to see the allergist and he also prescribed zrytek twice a day.  He suggested I take that for a few weeks to make sure the hives do not return.  It is March 9 and some of the hives are still there and bothersome, but the majority have resolved.
Pt. was administered his 2nd dose of Moderna at 22 days instead of the 28 days CDC was contacted and they did say the pt shall be okay and that he does not need to repeat the series
pt recvd vax; 6aug94 fever; apap given every 4 hrs & tepid baths; 7aug94 d; v; weak & limp; 8aug94 v; d; fever worse; turned purple; mom stated had convuls; to hosp;
Pt was given Pneumovax not at our office but at another one. Symptoms were provided by pt to us. Pt was not seen in OV. Pt C/O swollen right arm from elbow to axilla, hot to touch x 3.5 days.
dermatographia; hives; itching; redness in different part of body/ it starts in one part and then it moves to different area; full dose instead of booster; This spontaneous case was reported by a consumer and describes the occurrence of MECHANICAL URTICARIA (dermatographia), URTICARIA (hives), PRURITUS (itching), ERYTHEMA (redness in different part of body/ it starts in one part and then it moves to different area) and ACCIDENTAL OVERDOSE (full dose instead of booster) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043B21A, 012L20A and 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ACCIDENTAL OVERDOSE (full dose instead of booster). On an unknown date, the patient experienced MECHANICAL URTICARIA (dermatographia), URTICARIA (hives), PRURITUS (itching) and ERYTHEMA (redness in different part of body/ it starts in one part and then it moves to different area). On 22-Sep-2021, ACCIDENTAL OVERDOSE (full dose instead of booster) had resolved. At the time of the report, MECHANICAL URTICARIA (dermatographia), URTICARIA (hives), PRURITUS (itching) and ERYTHEMA (redness in different part of body/ it starts in one part and then it moves to different area) outcome was unknown.            No concomitant medications were reported.  It was reported that  few weeks after getting third dose, she started developing skin condition which was later diagnosed with dermatologist as" dermatographia",  It was reported that patient at the time she was travelling and booster shot was not available so she took full dose instead. Patient had no allergy or change in diet. Patient had has upcoming visit with allergist.  No treatment medications were reported.
Erythema surrounding injection site 14 x 14 cm, no induration, itching.
Chills; Headache; Body ache and pain; This is a spontaneous report from contactable consumer (patient) via medical information team. A female patient of unknown age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration as a single dose on 20Dec2020 for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unknown date, the patient experienced chills, headache, body ache and pain after receiving the Pfizer COVID-19 vaccine. Patient stated that she did not want to miss work. It was reported that the side effects she had are commonly reported with the vaccine. The outcome of the events were unknown.   No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
This is a spontaneous report from a contactable consumer via a sales representative and a contactable physician. A 71-year-old male patient received on 23OCT2014 the first dose of PREVNAR13; Lot Number: J23867; Expiration Date: 31JAN2016) intramuscular in the arm at 0.5 ml, single dose. Medical history included celiac disease, cholesterol, and hypertension. Concomitant medications included ZOCOR (table at 40 mg, for cholesterol), TOPROL at unknown dose for unspecified indication., BENICAR (tablet) at 20mg for hypertension, and ASPIRIN, all of which were ongoing. Within 2 to 4 hours of the injection, the patient's arm was totally swollen, red, hot and very painful. The swelling lasted for 4 days from 23OCT2014 to 26OCT2014. He was very tired from 23OCT2014 to 29OCT2014. The patient did not go to the hospital for any of the events. The clinical outcome of the events, patient's arm was red, hot and very painful, was recovered on unknown dates in 2014. The physician denied occurrence of the events. Follow-up (10NOV2014): New information obtained from a contactable physician includes: not medically confirmed. No follow-up attempts possible. No further information expected. Follow-Up (15DEC2014): New information received from the same contactable consumer includes: patient age, suspect product data, concomitant medications, reaction data, treatment, and outcome (recovered). Follow-up attempts completed. No further information expected.
Myalgia, fever, headache, shivers, respiratory infection, wheezing, flu like symptoms.
sore arm; This is a spontaneous report from a contactable consumer or other non hcp. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 12Mar2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient experienced sore arm. The outcome of the event was unknown.  Information about lot/batch number cannot be obtained. No further information expected.
Morning after shots, she noticed an itchy raised spot on her back.  Subsequently she developed 5 more lesions.  They were itchy, but then became painful.  They appear to be erythematous, papular with small excoriated centers. No pustules. Cough did seem worse, but she had other ill contacts in the family.
Spotting, bleeding, clotting, and cramping not associated with a regular menstrual period, lasting for two weeks.
A non-serious, spontaneous report of administration of expired product was received from a nurse concerning an eight year-old female subsequent to FLUMIST. There was no adverse event associated with this medication error; therefore treatment and reporter/sponsor causality assessments are not applicable and the event is considered resolved. Based on the results of the investigation, the root cause for the medication error were caused by 1) customers not discarding product form the previous season and 2) product expiring during the peak of flu season resulting in some medication errors that occurred shortly after the product expired. Additional information was received on 29-Jan-2009 and incorporated into the narrative: no adverse events reported after follow-up. Additional information received on 09-Apr-2009: product complaint investigation results.
Ringing in left ear that started 3 days after receiving the second dose of covid 19 vaccine.
This case was reported by a healthcare professional and described the occurrence of lip swelling in a 56-year-old female subject who was vaccinated with FLULAVAL (GlaxoSmithKline). The subject's medical history included arteriovenous malformation requiring brain surgery. Concurrent medical conditions included diabetes, high blood pressure, migraine, seizure and skin cancer (recent diagnosis). The migraine and seizure were a result of the brain surgery and were under care of a neurologist. Concurrent medications included verapamil, pravastatin, LEXAPRO, topiramate, metformin, vitamin D, fish oil, vitamin B12 and PRILOSEC. On an unspecified date "last year" (2010), the subject received a dose of INFLUENZA (unknown manufacturer). Two days after vaccination with influenza vaccine, the subject experienced flu-like symptoms of fever and pain ("achiness"). The events resolved after approximately 24 hours. The subject reported that last year was the first year she had experienced adverse events after receiving the flu vaccine. On 28 September 2011 the subject received a dose of FLULAVAL (unknown route, right arm). On 10 October 2011, 12 days after vaccination with FLULAVAL, the subject experienced lip swelling which got worse. She also experienced hives from head to toe. She was seen in her local emergency room because her eyes were almost swollen shut. The subject reported that she couldn't speak well because of her lips (speaking problem), but did think that the swelling had decreased. The subject also experienced headache, nocturnal awakening, nausea, upset stomach and flu like symptoms of sore throat and tiredness. The subject was treated with prednisone, ALLEGRA, PREVACID and famotidine. At the time of reporting the events of lip swelling, eyes almost swollen shut and speaking problem were improved. The event of hives was worse, and the outcome of the other events was unspecified.
Systemic: Numbness (specify: facial area, extremities)-Mild, Additional Details: pt reported he fell numbness(can not feel cold) on the anterior side of his left arm in 5 minutes after received vaccine. then in 15 minutes, they left, still have numbness. tried to contact parents several times. Finally, get hold-on the parents on 06/14/21. Mom said the numbness feeling lasted 2 days. Now he is fine. he will come to have 2nd dose on 06/15/21. will take benadryl and tylenol.
Injection site became red, swollen, and itchy. Injection given on 8/24/13, reaction was not immediate and began on 8-26/13 with redness, swelling and itching. Area is improving.
Patient got vaccine at a clinic this weekend. Our store was open at the time and she called here complaining of warm, red, solid, tender, hurts to touch.
No adverse events occurred- CDC notified, responded the vaccine will be counted as adolescent Tdap booster. Parent personally notified of vaccine error.
Within 15 minutes of receiving the vaccine the Pt experienced a brief loss of consciousness while in observation.  Upon assessment the Pt was hypotensive all other vitals were WNL. 911 was called and the Pt was transported to the hospital. Pt was conscious during transport.